Celie Johanna W A M, Keuning Eelco D, Beelen Robert H J, Dräger Angelika M, Zweegman Sonja, Kessler Floortje L, Soininen Raija, van den Born Jacob
Department of Molecular Cell Biology and Immunology, VU University Medical Center, 1007 MB, Amsterdam, the Netherlands.
J Biol Chem. 2005 Jul 22;280(29):26965-73. doi: 10.1074/jbc.M502188200. Epub 2005 May 24.
L-selectin is a C-type lectin expressed on leukocytes that is involved in both lymphocyte homing to the lymph node and leukocyte extravasation during inflammation. Known L-selectin ligands include sulfated Lewis-type carbohydrates, glycolipids, and proteoglycans. Previously, we have shown that in situ detection of different types of L-selectin ligands is highly dependent on the tissue fixation protocol used. Here we use this knowledge to specifically examine the expression of L-selectin binding proteoglycans in normal mouse tissues. We show that L-selectin binding chondroitin/dermatan sulfate proteoglycans are present in cartilage, whereas L-selectin binding heparan sulfate proteoglycans are present in spleen and kidney. Furthermore, we show that L-selectin only binds a subset of renal heparan sulfates, attached to a collagen type XVIII protein backbone and predominantly present in medullary tubular and vascular basement membranes. As L-selectin does not bind other renal heparan sulfate proteoglycans such as perlecan, agrin, and syndecan-4, and not all collagen type XVIII expressed in the kidney binds L-selectin, this indicates that there is a specific L-selectin binding domain on heparan sulfate glycosaminoglycan chains. Using an in vitro L-selectin binding assay, we studied the contribution of N-sulfation, O-sulfation, C5-epimerization, unsubstituted glucosamine residues, and chain length in L-selectin binding to heparan sulfate/heparin glycosaminoglycan chains. Based on our results and the accepted model of heparan sulfate domain organization, we propose a model for the interaction of L-selectin with heparan sulfate glycosaminoglycan chains. Interestingly, this opens the possibility of active regulation of L-selectin binding to heparan sulfate proteoglycans, e.g. under inflammatory conditions.
L-选择素是一种在白细胞上表达的C型凝集素,它参与淋巴细胞归巢至淋巴结以及炎症期间白细胞的渗出过程。已知的L-选择素配体包括硫酸化的Lewis型碳水化合物、糖脂和蛋白聚糖。此前,我们已经表明,不同类型L-选择素配体的原位检测高度依赖于所使用的组织固定方案。在此,我们利用这一知识专门研究正常小鼠组织中L-选择素结合蛋白聚糖的表达。我们发现L-选择素结合的硫酸软骨素/硫酸皮肤素蛋白聚糖存在于软骨中,而L-选择素结合的硫酸乙酰肝素蛋白聚糖存在于脾脏和肾脏中。此外,我们表明L-选择素仅结合附着于XVIII型胶原蛋白主干且主要存在于髓质肾小管和血管基底膜中的一部分肾硫酸乙酰肝素。由于L-选择素不结合其他肾硫酸乙酰肝素蛋白聚糖,如基底膜聚糖、集聚蛋白和syndecan-4,并且并非肾脏中表达的所有XVIII型胶原蛋白都结合L-选择素,这表明硫酸乙酰肝素糖胺聚糖链上存在特定的L-选择素结合结构域。我们使用体外L-选择素结合试验,研究了N-硫酸化、O-硫酸化、C5-表异构化、未取代的葡糖胺残基以及链长在L-选择素与硫酸乙酰肝素/肝素糖胺聚糖链结合中的作用。基于我们的结果以及公认的硫酸乙酰肝素结构域组织模型,我们提出了一个L-选择素与硫酸乙酰肝素糖胺聚糖链相互作用的模型。有趣的是,这开启了在例如炎症条件下对L-选择素与硫酸乙酰肝素蛋白聚糖结合进行活性调节的可能性。